▶ 調査レポート

世界のRNA分析/トランスクリプトーム市場規模・現状・予測(2021年-2027年)

• 英文タイトル:Global RNA Analysis /Transcriptomic Market Size, Status and Forecast 2021-2027

QYResearchが調査・発行した産業分析レポートです。世界のRNA分析/トランスクリプトーム市場規模・現状・予測(2021年-2027年) / Global RNA Analysis /Transcriptomic Market Size, Status and Forecast 2021-2027 / QFJ1-2605資料のイメージです。• レポートコード:QFJ1-2605
• 出版社/出版日:QYResearch / 2021年6月
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、124ページ
• 納品方法:Eメール(納期:3日)
• 産業分類:消費材
• 販売価格(消費税別)
  Single User¥577,200 (USD3,900)▷ お問い合わせ
  Multi User¥865,800 (USD5,850)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社発行の本調査レポートでは、RNA分析/トランスクリプトームの世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(マイクロアレイ、シーケンシング、ポリメラーゼ連鎖反応、RNA干渉)、用途別市場規模(臨床診断、創薬、トキシコゲノミクス、比較トランスクリプトミクス)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・RNA分析/トランスクリプトームの市場動向
・企業の競争状況、市場シェア
・RNA分析/トランスクリプトームの種類別市場規模と予測2016-2027(マイクロアレイ、シーケンシング、ポリメラーゼ連鎖反応、RNA干渉)
・RNA分析/トランスクリプトームの用途別市場規模と予測2016-2027(臨床診断、創薬、トキシコゲノミクス、比較トランスクリプトミクス)
・RNA分析/トランスクリプトームの北米市場規模2016-2027(アメリカ、カナダ)
・RNA分析/トランスクリプトームの欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・RNA分析/トランスクリプトームのアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・RNA分析/トランスクリプトームの中南米市場規模2016-2027(メキシコ、ブラジル)
・RNA分析/トランスクリプトームの中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Thermo Fisher Scientific, Inc.、Bio-Rad Laboratories, Inc.、Merck KGaA、Agilent Technologies, Inc.、F. Hoffmann-La Roche Ltd.、Danaher Corporation、Fluidigm Corporation、Eurofins Scientific、Sequentia Biotech SL、Acobiom、GenXPro GmbH、CD Genomics、Promega Corporation、Cenix BioScience GmbH、Takara Holdings, Inc.、bioMérieux SA、LC Sciences LLC)
・結論

Market Analysis and Insights: Global RNA Analysis /Transcriptomic Market
The global RNA Analysis /Transcriptomic market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global RNA Analysis /Transcriptomic market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global RNA Analysis /Transcriptomic market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global RNA Analysis /Transcriptomic market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global RNA Analysis /Transcriptomic market.

Global RNA Analysis /Transcriptomic Scope and Market Size
RNA Analysis /Transcriptomic market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global RNA Analysis /Transcriptomic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Microarrays
Sequencing
Polymerase Chain Reaction
RNA Interference

Segment by Application
Clinical Diagnostics
Drug Discovery
Toxicogenomics
Comparative Transcriptomics

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Thermo Fisher Scientific, Inc.
Bio-Rad Laboratories, Inc.
Merck KGaA
Agilent Technologies, Inc.
F. Hoffmann-La Roche Ltd.
Danaher Corporation
Fluidigm Corporation
Eurofins Scientific
Sequentia Biotech SL
Acobiom
GenXPro GmbH
CD Genomics
Promega Corporation
Cenix BioScience GmbH
Takara Holdings, Inc.
bioMérieux SA
LC Sciences LLC

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global RNA Analysis /Transcriptomic Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Microarrays
1.2.3 Sequencing
1.2.4 Polymerase Chain Reaction
1.2.5 RNA Interference
1.3 Market by Application
1.3.1 Global RNA Analysis /Transcriptomic Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Clinical Diagnostics
1.3.3 Drug Discovery
1.3.4 Toxicogenomics
1.3.5 Comparative Transcriptomics
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global RNA Analysis /Transcriptomic Market Perspective (2016-2027)
2.2 RNA Analysis /Transcriptomic Growth Trends by Regions
2.2.1 RNA Analysis /Transcriptomic Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 RNA Analysis /Transcriptomic Historic Market Share by Regions (2016-2021)
2.2.3 RNA Analysis /Transcriptomic Forecasted Market Size by Regions (2022-2027)
2.3 RNA Analysis /Transcriptomic Industry Dynamic
2.3.1 RNA Analysis /Transcriptomic Market Trends
2.3.2 RNA Analysis /Transcriptomic Market Drivers
2.3.3 RNA Analysis /Transcriptomic Market Challenges
2.3.4 RNA Analysis /Transcriptomic Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top RNA Analysis /Transcriptomic Players by Revenue
3.1.1 Global Top RNA Analysis /Transcriptomic Players by Revenue (2016-2021)
3.1.2 Global RNA Analysis /Transcriptomic Revenue Market Share by Players (2016-2021)
3.2 Global RNA Analysis /Transcriptomic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by RNA Analysis /Transcriptomic Revenue
3.4 Global RNA Analysis /Transcriptomic Market Concentration Ratio
3.4.1 Global RNA Analysis /Transcriptomic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by RNA Analysis /Transcriptomic Revenue in 2020
3.5 RNA Analysis /Transcriptomic Key Players Head office and Area Served
3.6 Key Players RNA Analysis /Transcriptomic Product Solution and Service
3.7 Date of Enter into RNA Analysis /Transcriptomic Market
3.8 Mergers & Acquisitions, Expansion Plans

4 RNA Analysis /Transcriptomic Breakdown Data by Type
4.1 Global RNA Analysis /Transcriptomic Historic Market Size by Type (2016-2021)
4.2 Global RNA Analysis /Transcriptomic Forecasted Market Size by Type (2022-2027)

5 RNA Analysis /Transcriptomic Breakdown Data by Application
5.1 Global RNA Analysis /Transcriptomic Historic Market Size by Application (2016-2021)
5.2 Global RNA Analysis /Transcriptomic Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America RNA Analysis /Transcriptomic Market Size (2016-2027)
6.2 North America RNA Analysis /Transcriptomic Market Size by Type
6.2.1 North America RNA Analysis /Transcriptomic Market Size by Type (2016-2021)
6.2.2 North America RNA Analysis /Transcriptomic Market Size by Type (2022-2027)
6.2.3 North America RNA Analysis /Transcriptomic Market Size by Type (2016-2027)
6.3 North America RNA Analysis /Transcriptomic Market Size by Application
6.3.1 North America RNA Analysis /Transcriptomic Market Size by Application (2016-2021)
6.3.2 North America RNA Analysis /Transcriptomic Market Size by Application (2022-2027)
6.3.3 North America RNA Analysis /Transcriptomic Market Size by Application (2016-2027)
6.4 North America RNA Analysis /Transcriptomic Market Size by Country
6.4.1 North America RNA Analysis /Transcriptomic Market Size by Country (2016-2021)
6.4.2 North America RNA Analysis /Transcriptomic Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe RNA Analysis /Transcriptomic Market Size (2016-2027)
7.2 Europe RNA Analysis /Transcriptomic Market Size by Type
7.2.1 Europe RNA Analysis /Transcriptomic Market Size by Type (2016-2021)
7.2.2 Europe RNA Analysis /Transcriptomic Market Size by Type (2022-2027)
7.2.3 Europe RNA Analysis /Transcriptomic Market Size by Type (2016-2027)
7.3 Europe RNA Analysis /Transcriptomic Market Size by Application
7.3.1 Europe RNA Analysis /Transcriptomic Market Size by Application (2016-2021)
7.3.2 Europe RNA Analysis /Transcriptomic Market Size by Application (2022-2027)
7.3.3 Europe RNA Analysis /Transcriptomic Market Size by Application (2016-2027)
7.4 Europe RNA Analysis /Transcriptomic Market Size by Country
7.4.1 Europe RNA Analysis /Transcriptomic Market Size by Country (2016-2021)
7.4.2 Europe RNA Analysis /Transcriptomic Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific RNA Analysis /Transcriptomic Market Size (2016-2027)
8.2 Asia-Pacific RNA Analysis /Transcriptomic Market Size by Type
8.2.1 Asia-Pacific RNA Analysis /Transcriptomic Market Size by Type (2016-2021)
8.2.2 Asia-Pacific RNA Analysis /Transcriptomic Market Size by Type (2022-2027)
8.2.3 Asia-Pacific RNA Analysis /Transcriptomic Market Size by Type (2016-2027)
8.3 Asia-Pacific RNA Analysis /Transcriptomic Market Size by Application
8.3.1 Asia-Pacific RNA Analysis /Transcriptomic Market Size by Application (2016-2021)
8.3.2 Asia-Pacific RNA Analysis /Transcriptomic Market Size by Application (2022-2027)
8.3.3 Asia-Pacific RNA Analysis /Transcriptomic Market Size by Application (2016-2027)
8.4 Asia-Pacific RNA Analysis /Transcriptomic Market Size by Region
8.4.1 Asia-Pacific RNA Analysis /Transcriptomic Market Size by Region (2016-2021)
8.4.2 Asia-Pacific RNA Analysis /Transcriptomic Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America RNA Analysis /Transcriptomic Market Size (2016-2027)
9.2 Latin America RNA Analysis /Transcriptomic Market Size by Type
9.2.1 Latin America RNA Analysis /Transcriptomic Market Size by Type (2016-2021)
9.2.2 Latin America RNA Analysis /Transcriptomic Market Size by Type (2022-2027)
9.2.3 Latin America RNA Analysis /Transcriptomic Market Size by Type (2016-2027)
9.3 Latin America RNA Analysis /Transcriptomic Market Size by Application
9.3.1 Latin America RNA Analysis /Transcriptomic Market Size by Application (2016-2021)
9.3.2 Latin America RNA Analysis /Transcriptomic Market Size by Application (2022-2027)
9.3.3 Latin America RNA Analysis /Transcriptomic Market Size by Application (2016-2027)
9.4 Latin America RNA Analysis /Transcriptomic Market Size by Country
9.4.1 Latin America RNA Analysis /Transcriptomic Market Size by Country (2016-2021)
9.4.2 Latin America RNA Analysis /Transcriptomic Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa RNA Analysis /Transcriptomic Market Size (2016-2027)
10.2 Middle East & Africa RNA Analysis /Transcriptomic Market Size by Type
10.2.1 Middle East & Africa RNA Analysis /Transcriptomic Market Size by Type (2016-2021)
10.2.2 Middle East & Africa RNA Analysis /Transcriptomic Market Size by Type (2022-2027)
10.2.3 Middle East & Africa RNA Analysis /Transcriptomic Market Size by Type (2016-2027)
10.3 Middle East & Africa RNA Analysis /Transcriptomic Market Size by Application
10.3.1 Middle East & Africa RNA Analysis /Transcriptomic Market Size by Application (2016-2021)
10.3.2 Middle East & Africa RNA Analysis /Transcriptomic Market Size by Application (2022-2027)
10.3.3 Middle East & Africa RNA Analysis /Transcriptomic Market Size by Application (2016-2027)
10.4 Middle East & Africa RNA Analysis /Transcriptomic Market Size by Country
10.4.1 Middle East & Africa RNA Analysis /Transcriptomic Market Size by Country (2016-2021)
10.4.2 Middle East & Africa RNA Analysis /Transcriptomic Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Thermo Fisher Scientific, Inc.
11.1.1 Thermo Fisher Scientific, Inc. Company Details
11.1.2 Thermo Fisher Scientific, Inc. Business Overview
11.1.3 Thermo Fisher Scientific, Inc. RNA Analysis /Transcriptomic Introduction
11.1.4 Thermo Fisher Scientific, Inc. Revenue in RNA Analysis /Transcriptomic Business (2016-2021)
11.1.5 Thermo Fisher Scientific, Inc. Recent Development
11.2 Bio-Rad Laboratories, Inc.
11.2.1 Bio-Rad Laboratories, Inc. Company Details
11.2.2 Bio-Rad Laboratories, Inc. Business Overview
11.2.3 Bio-Rad Laboratories, Inc. RNA Analysis /Transcriptomic Introduction
11.2.4 Bio-Rad Laboratories, Inc. Revenue in RNA Analysis /Transcriptomic Business (2016-2021)
11.2.5 Bio-Rad Laboratories, Inc. Recent Development
11.3 Merck KGaA
11.3.1 Merck KGaA Company Details
11.3.2 Merck KGaA Business Overview
11.3.3 Merck KGaA RNA Analysis /Transcriptomic Introduction
11.3.4 Merck KGaA Revenue in RNA Analysis /Transcriptomic Business (2016-2021)
11.3.5 Merck KGaA Recent Development
11.4 Agilent Technologies, Inc.
11.4.1 Agilent Technologies, Inc. Company Details
11.4.2 Agilent Technologies, Inc. Business Overview
11.4.3 Agilent Technologies, Inc. RNA Analysis /Transcriptomic Introduction
11.4.4 Agilent Technologies, Inc. Revenue in RNA Analysis /Transcriptomic Business (2016-2021)
11.4.5 Agilent Technologies, Inc. Recent Development
11.5 F. Hoffmann-La Roche Ltd.
11.5.1 F. Hoffmann-La Roche Ltd. Company Details
11.5.2 F. Hoffmann-La Roche Ltd. Business Overview
11.5.3 F. Hoffmann-La Roche Ltd. RNA Analysis /Transcriptomic Introduction
11.5.4 F. Hoffmann-La Roche Ltd. Revenue in RNA Analysis /Transcriptomic Business (2016-2021)
11.5.5 F. Hoffmann-La Roche Ltd. Recent Development
11.6 Danaher Corporation
11.6.1 Danaher Corporation Company Details
11.6.2 Danaher Corporation Business Overview
11.6.3 Danaher Corporation RNA Analysis /Transcriptomic Introduction
11.6.4 Danaher Corporation Revenue in RNA Analysis /Transcriptomic Business (2016-2021)
11.6.5 Danaher Corporation Recent Development
11.7 Fluidigm Corporation
11.7.1 Fluidigm Corporation Company Details
11.7.2 Fluidigm Corporation Business Overview
11.7.3 Fluidigm Corporation RNA Analysis /Transcriptomic Introduction
11.7.4 Fluidigm Corporation Revenue in RNA Analysis /Transcriptomic Business (2016-2021)
11.7.5 Fluidigm Corporation Recent Development
11.8 Eurofins Scientific
11.8.1 Eurofins Scientific Company Details
11.8.2 Eurofins Scientific Business Overview
11.8.3 Eurofins Scientific RNA Analysis /Transcriptomic Introduction
11.8.4 Eurofins Scientific Revenue in RNA Analysis /Transcriptomic Business (2016-2021)
11.8.5 Eurofins Scientific Recent Development
11.9 Sequentia Biotech SL
11.9.1 Sequentia Biotech SL Company Details
11.9.2 Sequentia Biotech SL Business Overview
11.9.3 Sequentia Biotech SL RNA Analysis /Transcriptomic Introduction
11.9.4 Sequentia Biotech SL Revenue in RNA Analysis /Transcriptomic Business (2016-2021)
11.9.5 Sequentia Biotech SL Recent Development
11.10 Acobiom
11.10.1 Acobiom Company Details
11.10.2 Acobiom Business Overview
11.10.3 Acobiom RNA Analysis /Transcriptomic Introduction
11.10.4 Acobiom Revenue in RNA Analysis /Transcriptomic Business (2016-2021)
11.10.5 Acobiom Recent Development
11.11 GenXPro GmbH
11.11.1 GenXPro GmbH Company Details
11.11.2 GenXPro GmbH Business Overview
11.11.3 GenXPro GmbH RNA Analysis /Transcriptomic Introduction
11.11.4 GenXPro GmbH Revenue in RNA Analysis /Transcriptomic Business (2016-2021)
11.11.5 GenXPro GmbH Recent Development
11.12 CD Genomics
11.12.1 CD Genomics Company Details
11.12.2 CD Genomics Business Overview
11.12.3 CD Genomics RNA Analysis /Transcriptomic Introduction
11.12.4 CD Genomics Revenue in RNA Analysis /Transcriptomic Business (2016-2021)
11.12.5 CD Genomics Recent Development
11.13 Promega Corporation
11.13.1 Promega Corporation Company Details
11.13.2 Promega Corporation Business Overview
11.13.3 Promega Corporation RNA Analysis /Transcriptomic Introduction
11.13.4 Promega Corporation Revenue in RNA Analysis /Transcriptomic Business (2016-2021)
11.13.5 Promega Corporation Recent Development
11.14 Cenix BioScience GmbH
11.14.1 Cenix BioScience GmbH Company Details
11.14.2 Cenix BioScience GmbH Business Overview
11.14.3 Cenix BioScience GmbH RNA Analysis /Transcriptomic Introduction
11.14.4 Cenix BioScience GmbH Revenue in RNA Analysis /Transcriptomic Business (2016-2021)
11.14.5 Cenix BioScience GmbH Recent Development
11.15 Takara Holdings, Inc.
11.15.1 Takara Holdings, Inc. Company Details
11.15.2 Takara Holdings, Inc. Business Overview
11.15.3 Takara Holdings, Inc. RNA Analysis /Transcriptomic Introduction
11.15.4 Takara Holdings, Inc. Revenue in RNA Analysis /Transcriptomic Business (2016-2021)
11.15.5 Takara Holdings, Inc. Recent Development
11.16 bioMérieux SA
11.16.1 bioMérieux SA Company Details
11.16.2 bioMérieux SA Business Overview
11.16.3 bioMérieux SA RNA Analysis /Transcriptomic Introduction
11.16.4 bioMérieux SA Revenue in RNA Analysis /Transcriptomic Business (2016-2021)
11.16.5 bioMérieux SA Recent Development
11.17 LC Sciences LLC
11.17.1 LC Sciences LLC Company Details
11.17.2 LC Sciences LLC Business Overview
11.17.3 LC Sciences LLC RNA Analysis /Transcriptomic Introduction
11.17.4 LC Sciences LLC Revenue in RNA Analysis /Transcriptomic Business (2016-2021)
11.17.5 LC Sciences LLC Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global RNA Analysis /Transcriptomic Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Microarrays
Table 3. Key Players of Sequencing
Table 4. Key Players of Polymerase Chain Reaction
Table 5. Key Players of RNA Interference
Table 6. Global RNA Analysis /Transcriptomic Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global RNA Analysis /Transcriptomic Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global RNA Analysis /Transcriptomic Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global RNA Analysis /Transcriptomic Market Share by Regions (2016-2021)
Table 10. Global RNA Analysis /Transcriptomic Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global RNA Analysis /Transcriptomic Market Share by Regions (2022-2027)
Table 12. RNA Analysis /Transcriptomic Market Trends
Table 13. RNA Analysis /Transcriptomic Market Drivers
Table 14. RNA Analysis /Transcriptomic Market Challenges
Table 15. RNA Analysis /Transcriptomic Market Restraints
Table 16. Global RNA Analysis /Transcriptomic Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global RNA Analysis /Transcriptomic Market Share by Players (2016-2021)
Table 18. Global Top RNA Analysis /Transcriptomic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in RNA Analysis /Transcriptomic as of 2020)
Table 19. Ranking of Global Top RNA Analysis /Transcriptomic Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by RNA Analysis /Transcriptomic Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players RNA Analysis /Transcriptomic Product Solution and Service
Table 23. Date of Enter into RNA Analysis /Transcriptomic Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global RNA Analysis /Transcriptomic Market Size by Type (2016-2021) (US$ Million)
Table 26. Global RNA Analysis /Transcriptomic Revenue Market Share by Type (2016-2021)
Table 27. Global RNA Analysis /Transcriptomic Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global RNA Analysis /Transcriptomic Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global RNA Analysis /Transcriptomic Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global RNA Analysis /Transcriptomic Revenue Market Share by Application (2016-2021)
Table 31. Global RNA Analysis /Transcriptomic Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global RNA Analysis /Transcriptomic Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America RNA Analysis /Transcriptomic Market Size by Type (2016-2021) (US$ Million)
Table 34. North America RNA Analysis /Transcriptomic Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America RNA Analysis /Transcriptomic Market Size by Application (2016-2021) (US$ Million)
Table 36. North America RNA Analysis /Transcriptomic Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America RNA Analysis /Transcriptomic Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America RNA Analysis /Transcriptomic Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe RNA Analysis /Transcriptomic Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe RNA Analysis /Transcriptomic Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe RNA Analysis /Transcriptomic Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe RNA Analysis /Transcriptomic Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe RNA Analysis /Transcriptomic Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe RNA Analysis /Transcriptomic Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific RNA Analysis /Transcriptomic Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific RNA Analysis /Transcriptomic Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific RNA Analysis /Transcriptomic Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific RNA Analysis /Transcriptomic Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific RNA Analysis /Transcriptomic Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific RNA Analysis /Transcriptomic Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America RNA Analysis /Transcriptomic Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America RNA Analysis /Transcriptomic Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America RNA Analysis /Transcriptomic Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America RNA Analysis /Transcriptomic Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America RNA Analysis /Transcriptomic Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America RNA Analysis /Transcriptomic Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa RNA Analysis /Transcriptomic Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa RNA Analysis /Transcriptomic Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa RNA Analysis /Transcriptomic Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa RNA Analysis /Transcriptomic Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa RNA Analysis /Transcriptomic Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa RNA Analysis /Transcriptomic Market Size by Country (2022-2027) & (US$ Million)
Table 63. Thermo Fisher Scientific, Inc. Company Details
Table 64. Thermo Fisher Scientific, Inc. Business Overview
Table 65. Thermo Fisher Scientific, Inc. RNA Analysis /Transcriptomic Product
Table 66. Thermo Fisher Scientific, Inc. Revenue in RNA Analysis /Transcriptomic Business (2016-2021) & (US$ Million)
Table 67. Thermo Fisher Scientific, Inc. Recent Development
Table 68. Bio-Rad Laboratories, Inc. Company Details
Table 69. Bio-Rad Laboratories, Inc. Business Overview
Table 70. Bio-Rad Laboratories, Inc. RNA Analysis /Transcriptomic Product
Table 71. Bio-Rad Laboratories, Inc. Revenue in RNA Analysis /Transcriptomic Business (2016-2021) & (US$ Million)
Table 72. Bio-Rad Laboratories, Inc. Recent Development
Table 73. Merck KGaA Company Details
Table 74. Merck KGaA Business Overview
Table 75. Merck KGaA RNA Analysis /Transcriptomic Product
Table 76. Merck KGaA Revenue in RNA Analysis /Transcriptomic Business (2016-2021) & (US$ Million)
Table 77. Merck KGaA Recent Development
Table 78. Agilent Technologies, Inc. Company Details
Table 79. Agilent Technologies, Inc. Business Overview
Table 80. Agilent Technologies, Inc. RNA Analysis /Transcriptomic Product
Table 81. Agilent Technologies, Inc. Revenue in RNA Analysis /Transcriptomic Business (2016-2021) & (US$ Million)
Table 82. Agilent Technologies, Inc. Recent Development
Table 83. F. Hoffmann-La Roche Ltd. Company Details
Table 84. F. Hoffmann-La Roche Ltd. Business Overview
Table 85. F. Hoffmann-La Roche Ltd. RNA Analysis /Transcriptomic Product
Table 86. F. Hoffmann-La Roche Ltd. Revenue in RNA Analysis /Transcriptomic Business (2016-2021) & (US$ Million)
Table 87. F. Hoffmann-La Roche Ltd. Recent Development
Table 88. Danaher Corporation Company Details
Table 89. Danaher Corporation Business Overview
Table 90. Danaher Corporation RNA Analysis /Transcriptomic Product
Table 91. Danaher Corporation Revenue in RNA Analysis /Transcriptomic Business (2016-2021) & (US$ Million)
Table 92. Danaher Corporation Recent Development
Table 93. Fluidigm Corporation Company Details
Table 94. Fluidigm Corporation Business Overview
Table 95. Fluidigm Corporation RNA Analysis /Transcriptomic Product
Table 96. Fluidigm Corporation Revenue in RNA Analysis /Transcriptomic Business (2016-2021) & (US$ Million)
Table 97. Fluidigm Corporation Recent Development
Table 98. Eurofins Scientific Company Details
Table 99. Eurofins Scientific Business Overview
Table 100. Eurofins Scientific Revenue in RNA Analysis /Transcriptomic Business (2016-2021) & (US$ Million)
Table 101. Eurofins Scientific Recent Development
Table 102. Sequentia Biotech SL Company Details
Table 103. Sequentia Biotech SL Business Overview
Table 104. Sequentia Biotech SL RNA Analysis /Transcriptomic Product
Table 105. Sequentia Biotech SL Revenue in RNA Analysis /Transcriptomic Business (2016-2021) & (US$ Million)
Table 106. Sequentia Biotech SL Recent Development
Table 107. Acobiom Company Details
Table 108. Acobiom Business Overview
Table 109. Acobiom RNA Analysis /Transcriptomic Product
Table 110. Acobiom Revenue in RNA Analysis /Transcriptomic Business (2016-2021) & (US$ Million)
Table 111. Acobiom Recent Development
Table 112. GenXPro GmbH Company Details
Table 113. GenXPro GmbH Business Overview
Table 114. GenXPro GmbH RNA Analysis /Transcriptomic Product
Table 115. GenXPro GmbH Revenue in RNA Analysis /Transcriptomic Business (2016-2021) & (US$ Million)
Table 116. GenXPro GmbH Recent Development
Table 117. CD Genomics Company Details
Table 118. CD Genomics Business Overview
Table 119. CD Genomics RNA Analysis /Transcriptomic Product
Table 120. CD Genomics Revenue in RNA Analysis /Transcriptomic Business (2016-2021) & (US$ Million)
Table 121. CD Genomics Recent Development
Table 122. Promega Corporation Company Details
Table 123. Promega Corporation Business Overview
Table 124. Promega Corporation RNA Analysis /Transcriptomic Product
Table 125. Promega Corporation Revenue in RNA Analysis /Transcriptomic Business (2016-2021) & (US$ Million)
Table 126. Promega Corporation Recent Development
Table 127. Cenix BioScience GmbH Company Details
Table 128. Cenix BioScience GmbH Business Overview
Table 129. Cenix BioScience GmbH RNA Analysis /Transcriptomic Product
Table 130. Cenix BioScience GmbH Revenue in RNA Analysis /Transcriptomic Business (2016-2021) & (US$ Million)
Table 131. Cenix BioScience GmbH Recent Development
Table 132. Takara Holdings, Inc. Company Details
Table 133. Takara Holdings, Inc. Business Overview
Table 134. Takara Holdings, Inc. RNA Analysis /Transcriptomic Product
Table 135. Takara Holdings, Inc. Revenue in RNA Analysis /Transcriptomic Business (2016-2021) & (US$ Million)
Table 136. Takara Holdings, Inc. Recent Development
Table 137. bioMérieux SA Company Details
Table 138. bioMérieux SA Business Overview
Table 139. bioMérieux SA RNA Analysis /Transcriptomic Product
Table 140. bioMérieux SA Revenue in RNA Analysis /Transcriptomic Business (2016-2021) & (US$ Million)
Table 141. bioMérieux SA Recent Development
Table 142. LC Sciences LLC Company Details
Table 143. LC Sciences LLC Business Overview
Table 144. LC Sciences LLC RNA Analysis /Transcriptomic Product
Table 145. LC Sciences LLC Revenue in RNA Analysis /Transcriptomic Business (2016-2021) & (US$ Million)
Table 146. LC Sciences LLC Recent Development
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
List of Figures
Figure 1. Global RNA Analysis /Transcriptomic Market Share by Type: 2020 VS 2027
Figure 2. Microarrays Features
Figure 3. Sequencing Features
Figure 4. Polymerase Chain Reaction Features
Figure 5. RNA Interference Features
Figure 6. Global RNA Analysis /Transcriptomic Market Share by Application: 2020 VS 2027
Figure 7. Clinical Diagnostics Case Studies
Figure 8. Drug Discovery Case Studies
Figure 9. Toxicogenomics Case Studies
Figure 10. Comparative Transcriptomics Case Studies
Figure 11. RNA Analysis /Transcriptomic Report Years Considered
Figure 12. Global RNA Analysis /Transcriptomic Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global RNA Analysis /Transcriptomic Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global RNA Analysis /Transcriptomic Market Share by Regions: 2020 VS 2027
Figure 15. Global RNA Analysis /Transcriptomic Market Share by Regions (2022-2027)
Figure 16. Global RNA Analysis /Transcriptomic Market Share by Players in 2020
Figure 17. Global Top RNA Analysis /Transcriptomic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in RNA Analysis /Transcriptomic as of 2020
Figure 18. The Top 10 and 5 Players Market Share by RNA Analysis /Transcriptomic Revenue in 2020
Figure 19. Global RNA Analysis /Transcriptomic Revenue Market Share by Type (2016-2021)
Figure 20. Global RNA Analysis /Transcriptomic Revenue Market Share by Type (2022-2027)
Figure 21. North America RNA Analysis /Transcriptomic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America RNA Analysis /Transcriptomic Market Share by Type (2016-2027)
Figure 23. North America RNA Analysis /Transcriptomic Market Share by Application (2016-2027)
Figure 24. North America RNA Analysis /Transcriptomic Market Share by Country (2016-2027)
Figure 25. United States RNA Analysis /Transcriptomic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada RNA Analysis /Transcriptomic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe RNA Analysis /Transcriptomic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe RNA Analysis /Transcriptomic Market Share by Type (2016-2027)
Figure 29. Europe RNA Analysis /Transcriptomic Market Share by Application (2016-2027)
Figure 30. Europe RNA Analysis /Transcriptomic Market Share by Country (2016-2027)
Figure 31. Germany RNA Analysis /Transcriptomic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France RNA Analysis /Transcriptomic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. RNA Analysis /Transcriptomic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy RNA Analysis /Transcriptomic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia RNA Analysis /Transcriptomic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic RNA Analysis /Transcriptomic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific RNA Analysis /Transcriptomic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific RNA Analysis /Transcriptomic Market Share by Type (2016-2027)
Figure 39. Asia-Pacific RNA Analysis /Transcriptomic Market Share by Application (2016-2027)
Figure 40. Asia-Pacific RNA Analysis /Transcriptomic Market Share by Region (2016-2027)
Figure 41. China RNA Analysis /Transcriptomic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan RNA Analysis /Transcriptomic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea RNA Analysis /Transcriptomic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia RNA Analysis /Transcriptomic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India RNA Analysis /Transcriptomic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia RNA Analysis /Transcriptomic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America RNA Analysis /Transcriptomic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America RNA Analysis /Transcriptomic Market Share by Type (2016-2027)
Figure 49. Latin America RNA Analysis /Transcriptomic Market Share by Application (2016-2027)
Figure 50. Latin America RNA Analysis /Transcriptomic Market Share by Country (2016-2027)
Figure 51. Mexico RNA Analysis /Transcriptomic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil RNA Analysis /Transcriptomic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa RNA Analysis /Transcriptomic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa RNA Analysis /Transcriptomic Market Share by Type (2016-2027)
Figure 55. Middle East & Africa RNA Analysis /Transcriptomic Market Share by Application (2016-2027)
Figure 56. Middle East & Africa RNA Analysis /Transcriptomic Market Share by Country (2016-2027)
Figure 57. Turkey RNA Analysis /Transcriptomic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia RNA Analysis /Transcriptomic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE RNA Analysis /Transcriptomic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Thermo Fisher Scientific, Inc. Revenue Growth Rate in RNA Analysis /Transcriptomic Business (2016-2021)
Figure 61. Bio-Rad Laboratories, Inc. Revenue Growth Rate in RNA Analysis /Transcriptomic Business (2016-2021)
Figure 62. Merck KGaA Revenue Growth Rate in RNA Analysis /Transcriptomic Business (2016-2021)
Figure 63. Agilent Technologies, Inc. Revenue Growth Rate in RNA Analysis /Transcriptomic Business (2016-2021)
Figure 64. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in RNA Analysis /Transcriptomic Business (2016-2021)
Figure 65. Danaher Corporation Revenue Growth Rate in RNA Analysis /Transcriptomic Business (2016-2021)
Figure 66. Fluidigm Corporation Revenue Growth Rate in RNA Analysis /Transcriptomic Business (2016-2021)
Figure 67. Eurofins Scientific Revenue Growth Rate in RNA Analysis /Transcriptomic Business (2016-2021)
Figure 68. Sequentia Biotech SL Revenue Growth Rate in RNA Analysis /Transcriptomic Business (2016-2021)
Figure 69. Acobiom Revenue Growth Rate in RNA Analysis /Transcriptomic Business (2016-2021)
Figure 70. GenXPro GmbH Revenue Growth Rate in RNA Analysis /Transcriptomic Business (2016-2021)
Figure 71. CD Genomics Revenue Growth Rate in RNA Analysis /Transcriptomic Business (2016-2021)
Figure 72. Promega Corporation Revenue Growth Rate in RNA Analysis /Transcriptomic Business (2016-2021)
Figure 73. Cenix BioScience GmbH Revenue Growth Rate in RNA Analysis /Transcriptomic Business (2016-2021)
Figure 74. Takara Holdings, Inc. Revenue Growth Rate in RNA Analysis /Transcriptomic Business (2016-2021)
Figure 75. bioMérieux SA Revenue Growth Rate in RNA Analysis /Transcriptomic Business (2016-2021)
Figure 76. LC Sciences LLC Revenue Growth Rate in RNA Analysis /Transcriptomic Business (2016-2021)
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed